What Researchers Did
This study investigated the underlying reasons for limited mouth opening in oral submucous fibrosis, proposing new mechanisms involving muscle damage, vascular changes, and lactate dehydrogenase, and discussing the impact of radiotherapy and potential therapeutic remedies.
What They Found
Researchers proposed that limited mouth opening in oral submucous fibrosis (OSF) is driven by muscle fibrosis, resulting from stretch-mediated muscle damage, specific vascular changes like endothelial dysfunction, and upregulated anaerobic isoforms of lactate dehydrogenase (LDH). They found that the extent of muscle fibrosis correlates with hypoxia-mediated upregulation of anaerobic LDH isoforms, and that radiotherapy exacerbates fibrosis by causing vascular damage. The study also highlighted that oral squamous cell carcinoma in OSF is an absolute contraindication for radiotherapy due to poor prognosis.
What This Means for Canadian Patients
Canadian patients with oral submucous fibrosis experiencing limited mouth opening may benefit from therapies targeting muscle damage, vascular changes, or hypoxia, such as hyperbaric oxygen therapy. It is crucial for patients with oral submucous fibrosis who develop oral squamous cell carcinoma to avoid radiotherapy, as it can worsen their prognosis.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
A limitation of this study is that it primarily proposes mechanisms and an algorithm without presenting specific new experimental data or a defined patient cohort to validate these findings.